The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.
about
Transcriptional regulation of BRCA1 expression by a metabolic switchBRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamicsCharacteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer Registry.Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancersMolecular insights on basal-like breast cancer.Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development.Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers.Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesisThe pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistanceAssessing Heavy Metal and PCB Exposure from Tap Water by Measuring Levels in Plasma from Sporadic Breast Cancer Patients, a Pilot Study.Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation.A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers.BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression.BRACking news on triple-negative/basal-like breast cancers: how BRCA1 deficiency may result in the development of a selective tumor subtype.Low-fidelity alternative DNA repair carcinogenesis theory may interpret many cancer features and anticancer strategies.Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue.Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720.BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients.Body weight and risk of breast cancer in BRCA1/2 mutation carriers.Responsiveness of Brca1 and Trp53 Deficiency-Induced Mammary Preneoplasia to Selective Estrogen Modulators versus an Aromatase Inhibitor in Mus musculus.Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese.
P2860
Q24307973-F50AEA4B-9EF7-476F-80C2-38297E962F59Q26822737-BDE50232-0E6A-4B91-A78F-20B73A99B54CQ28383242-9FF780E5-EF2F-4B9F-9709-B82D5081E58BQ30836057-6232600E-D4D1-4975-814A-21867A6FA476Q33748161-03D0A547-0951-4946-A91A-19832965C48FQ34123314-3DEB2C96-9A7E-44BF-9C02-DBA6337646EAQ34391427-D4E943AE-7696-41CA-A709-5956127BBC19Q35157919-B9F39247-F99A-4617-B61A-3AF6234C281EQ35633272-2F2320AE-3E3C-4A00-BB07-B9F5A72C25FCQ35881326-38EFA6DF-5409-43D6-B4AA-28470343166BQ35939435-5A5D9819-FA27-4918-968E-CE7A44DE9328Q36403687-21B76EF3-F39D-4B34-96BE-A742812E78ECQ36632405-1B9DD47A-E97D-4D23-8A43-599F373FC713Q37158337-8A3B3950-E7CB-4402-9F56-29DB066C93F8Q37400573-F2ABB007-32B8-41E1-A4E3-FDF400085E52Q37958686-69391CE7-308C-4A67-BBE7-A6C9A0B48276Q38868797-7BCECB89-88BD-441B-AA1A-E4B2B4C5A765Q39069405-E142C3A4-79E3-461C-AABA-F215F1E8E5A1Q41913139-0CFA18B2-14EF-4F68-AEC6-61099E5C9AC9Q43943310-B3A18ADA-D9F8-4522-B227-308967532BC9Q47418222-C9480FDF-ABC8-4381-903C-6345F3387758Q51102156-1083DAE7-33BB-4D46-9F58-5CC304E09965Q53279057-DC2616B4-66AB-4760-9379-8F96A27689C1
P2860
The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.
@en
The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.
@nl
type
label
The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.
@en
The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.
@nl
prefLabel
The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.
@en
The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.
@nl
P2093
P2860
P1476
The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.
@en
P2093
Alison M Hosey
D Paul Harkin
Julia J Gorski
Richard D Kennedy
P2860
P304
P356
10.1158/1078-0432.CCR-08-0640
P407
P577
2009-02-17T00:00:00Z